Comprehensive analysis of eosinophils and type 2 innate lymphoid cells in patients with severe asthma before and after mepolizumab treatment
- Conditions
- Severe asthma
- Registration Number
- JPRN-UMIN000052889
- Lead Sponsor
- Keio University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Not provided
Patients are not eligible for this study if they met any of the following criteria Has previously been treated with mepolizumab before the study Has a history of acute viral infection up to 4 weeks prior to blood sampling Has been treated with systemic corticosteroids including methylprednisolone up to 4 weeks prior to blood sampling History of widespread lung disease Has cancer/malignancy under treatment During the period of pregnancy Individuals whom the principal investigators judge as inappropriate registers Healthy volunteers are not eligible for this study if they met any of the following criteria: Has a history of acute viral infection up to 4 weeks prior to blood sampling Individuals whom the principal investigators judge as inappropriate registers
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method